Allison W. Kurian

22.8k citations

293 papers · 9.8k indexed · 5 hit papers · h-index 56

Cancer Research top 0.2%
- Breast Cancer Treatment Studies 66
- Cancer Genomics and Diagnostics 53
Oncology top 0.5%
- Global Cancer Incidence and Screening 57
- Cancer Risks and Factors 31
- Cancer survivorship and care 21
Genetics top 0.2%
- BRCA gene mutations in cancer 136
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 20
Reproductive Medicine top 1%
Economics and Econometrics
- Economic and Financial Impacts of Cancer 20

Co-authors: James M. Ford Christina A. Clarke Theresa H.M. Keegan Steven J. Katz Ann S. Hamilton Scarlett Lin Gomez Kevin C. Ward Sylvia K. Plevritis
Cited by: Cancer Research Oncology Genetics
Partner nations: United States Canada United Kingdom

In The Last Decade

Allison W. Kurian

272 papers receiving 9.6k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2024 Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
2023 Germline Genetic Testing After Cancer Diagnosis
2018 Differences in Breast Cancer Survival by Molecular Subtypes in the United States
2018 A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging

Peers

Countries citing papers authored by Allison W. Kurian

Since Specialization

Citations

This map shows the geographic impact of Allison W. Kurian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison W. Kurian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison W. Kurian more than expected).

Fields of papers citing papers by Allison W. Kurian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison W. Kurian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison W. Kurian. The network helps show where Allison W. Kurian may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Allison W. Kurian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Allison W. Kurian Line = papers co-authored together Allison W. Kurian links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Breast Cancer Risk Modification in Women with Pathogenic Variants in BRCA1 , BRCA2 , ATM , CHEK2 , and PALB2 Allison W. Kurian,Elisha Hughes,Ryan Bernhisel,Eudora Hu,Eric C. Polley,Siddhartha Yadav,Chunling Hu,Jennifer L. Caswell‐Jin,Esther M. John,Aladdin H. Shadyab,Rowan T. Chlebowski,Rami Nassir,Peter Kraft,Marcia L. Stefanick,Fergus J. Couch	2025	0
2	Susan G. Komen’s ShareForCures: a patient-engaged, nationwide breast cancer research registry Jérôme Jourquin,James Dickerson,Emily Marks,Jessica Epps,Kimberly Sabelko,Allison W. Kurian,Melissa L. Bondy	2025	0
3	Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study Anna Graber‐Naidich,Eunji Choi,Julie Wu,Timothy Ellis-Caleo,Joel W. Neal,Heather A. Wakelee,Allison W. Kurian,Summer S. Han	2024	1
4	Automated Extraction of Patient-Centered Outcomes After Breast Cancer Treatment: An Open-Source Large Language Model–Based Toolkit Man Luo,Shubham Trivedi,Allison W. Kurian,Kevin C. Ward,Theresa H.M. Keegan,Daniel L. Rubin,Imon Banerjee	2024	6
5	Changes in Breast Cancer Risk and Risk Factor Profiles among U.S.-Born and Immigrant Asian American Women Residing in the San Francisco Bay Area Esther M. John,Jocelyn Koo,Sue A. Ingles,Allison W. Kurian,Lisa M. Hines	2023	3
6	Clinical implications of conflicting variant interpretations in the cancer genetics clinic Elyssa Zukin,Julie O. Culver,Yuxi Liu,Yunqi Yang,Charité Ricker,Rachel Hodan,Duveen Sturgeon,Kerry Kingham,Nicolette M. Chun,Courtney Rowe‐Teeter,Kathryn Singh,Jason A. Zell,Uri Ladabaum,Kevin McDonnell,James M. Ford,Giovanni Parmigiani,Danielle Braun,Allison W. Kurian,Stephen B. Gruber,Gregory Idos	2023	3
7	Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study Steven J. Katz,Paul Abrahamse,Rachel Hodan,Allison W. Kurian,Aaron Rankin,Rachel Tocco,Sonia Rios‐Ventura,Kevin C. Ward,Lawrence C. An	2023	2
8	Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer Jinani Jayasekera,Amy Zhao,Clyde B. Schechter,Kathryn P. Lowry,Jennifer M. Yeh,Marc D. Schwartz,Suzanne C. O’Neill,Karen J. Wernli,Natasha K. Stout,Jeanne S. Mandelblatt,Allison W. Kurian,Claudine Isaacs	2022	11
9	Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated ( ATM ) Gene are Associated with High and Moderate Risks for Multiple Cancers Michael J. Hall,Ryan Bernhisel,Elisha Hughes,Katie Larson,Eric T. Rosenthal,Nanda A. Singh,Johnathan M. Lancaster,Allison W. Kurian	2021	102
10	Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer Allison W. Kurian,Paul Abrahamse,Irina Bondarenko,Ann S. Hamilton,Dennis Deapen,Scarlett Lin Gomez,Monica Morrow,Jonathan S. Berek,Timothy P. Hofer,Steven J. Katz,Kevin C. Ward	2021	9
11	Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model Shannon Gallagher,Elisha Hughes,Allison W. Kurian,Susan M. Domchek,Judy E. Garber,Braden Probst,Brian Morris,Placede Tshiaba,Stephanie Meek,Eric T. Rosenthal,Benjamin B. Roa,Thomas P. Slavin,Susanne Wagner,Jeffrey N. Weitzel,Alexander Gutin,Jerry S. Lanchbury,Mark E. Robson	2021	14
12	Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes Allison W. Kurian,Paul Abrahamse,Kevin C. Ward,Ann S. Hamilton,Dennis Deapen,Jonathan S. Berek,Lily Hoang,Amal Yussuf,Jill S. Dolinsky,Krystal Brown,Thomas Slavin,Timothy P. Hofer,Steven J. Katz	2021	5
13	Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer Anosheh Afghahi,Natasha Purington,Summer S. Han,Manisha Desai,Emma Pierson,Maya B. Mathur,Tina Seto,Caroline A. Thompson,Joseph Rigdon,Melinda L. Telli,Sunil Badve,Christina Curtis,Robert B. West,Kathleen C. Horst,Scarlett Lin Gomez,James M. Ford,George W. Sledge,Allison W. Kurian	2018	67
14	Macrophages Promote Circulating Tumor Cell–Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients Marjan Rafat,Todd A. Aguilera,Marta Vilalta,Laura Bronsart,Luis Soto,Rie von Eyben,Meghana Golla,Yasaman Ahrari,Stavros Melemenidis,Anosheh Afghahi,Melissa J. Jenkins,Allison W. Kurian,Kathleen C. Horst,Amato J. Giaccia,Edward E. Graves	2018	38
15	Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways Jia Wu,Yi Cui,Xiaoli Sun,Guohong Cao,Bailiang Li,Debra M. Ikeda,Allison W. Kurian,Ruijiang Li	2017	77
16	Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance Anosheh Afghahi,Kirsten M. Timms,Shaveta Vinayak,Kristin C. Jensen,Allison W. Kurian,Robert W. Carlson,Pei-Jen Chang,Elizabeth Schackmann,Anne‐Renee Hartman,James M. Ford,Melinda L. Telli	2017	55
17	The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality Richard Sposto,Theresa H.M. Keegan,Cheryl Vigen,Marilyn L. Kwan,Leslie Bernstein,Esther M. John,Iona Cheng,Juan Yang,Jocelyn Koo,Allison W. Kurian,Bette J. Caan,Yani Lu,Kristine R. Monroe,Salma Shariff‐Marco,Scarlett Lin Gomez,Anna H. Wu	2016	22
18	Contribution of the Neighborhood Environment and Obesity to Breast Cancer Survival: The California Breast Cancer Survivorship Consortium Iona Cheng,Salma Shariff‐Marco,Jocelyn Koo,Kristine R. Monroe,Juan Yang,Esther M. John,Allison W. Kurian,Marilyn L. Kwan,Brian E. Henderson,Leslie Bernstein,Yani Lu,Richard Sposto,Cheryl Vigen,Anna H. Wu,Scarlett Lin Gomez,Theresa H.M. Keegan	2015	27
19	A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers Bronislava M. Sigal,Diego F. Muñoz,Allison W. Kurian,Sylvia K. Plevritis	2012	30
20	Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers Allison W. Kurian,Bronislava M. Sigal,Sylvia K. Plevritis	2009	167

About Allison W. Kurian

Allison W. Kurian is a scholar working on Cancer Research, Genetics and Oncology, having authored 293 papers that have together received 9.8k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (136 papers), Breast Cancer Treatment Studies (66 papers), Global Cancer Incidence and Screening (57 papers), Cancer Genomics and Diagnostics (53 papers), Cancer Risks and Factors (31 papers), Cancer survivorship and care (21 papers), Genetic factors in colorectal cancer (20 papers) and Economic and Financial Impacts of Cancer (20 papers). The work is most often cited by research in Cancer Research (3.6k citations), Oncology (4.0k citations) and Genetics (3.9k citations). Allison W. Kurian has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include James M. Ford, Christina A. Clarke, Theresa H.M. Keegan, Steven J. Katz, Ann S. Hamilton, Scarlett Lin Gomez, Kevin C. Ward, Sylvia K. Plevritis, Nadia Howlader and Reshma Jagsi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact